Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F88PL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,797
Award facts
- Contract value 100% obligated
- $13,796.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,796.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on January 26, 2026, with completion expected by January 27, 2026. This non-set-aside award was competitively procured and performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems. The delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, an SPE2DX vehicle valued at $999,999,999.00 through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs.
Repatha is a prescription medication used to treat high cholesterol in patients at risk for cardiovascular disease. This delivery order fulfills specific medical supply requirements within DLA's broader pharmaceutical procurement strategy supporting military treatment facilities and other federal healthcare institutions. The award demonstrates AmerisourceBergen's continued role as a critical vendor in the federal medical supply chain, leveraging its established IDC to provide specialty medications and medical devices across multiple therapeutic domains to the Department of Defense and related government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F88PL?
SPE2DR26F88PL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F88PL worth?
The government has obligated $13,797 on SPE2DR26F88PL.
Is contract SPE2DR26F88PL an order under another contract?
Yes. SPE2DR26F88PL is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88PL competed?
The extent of competition for SPE2DR26F88PL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award